(Q28211805)

1

0 references

Mark Massing

2

0 references

Abhijit Kshirsagar

3

0 references

Ross J Simpson

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

5

0 references

language of work or name

English

0 references

publication date

November 2004

0 references

published in

Renal Failure

0 references

volume

26

0 references

issue

6

0 references

page(s)

715-25

0 references

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Diabetes and decline in heart disease mortality in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Lipid abnormalities in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Identifying confounding by indication through blinded prospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

MODERATE DOSES OF ASPIRIN AND RISK OF BLEEDING IN RENAL FAILURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110

DOES ASPIRIN PRECIPITATE MAJOR GASTROINTESTINAL BLEEDING IN PATIENTS ON HÆMODIALYSIS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200037110